Penitentiary Center Alicante II, Carretera N-330, Km. 66, 03400 Villena, Spain.
Servicio de Urgencias, Hospital Universitario del Vinalopó-Elche, Calle Tonico Sansano Mora, 03293 Elche, Spain.
Int J Environ Res Public Health. 2020 Oct 19;17(20):7589. doi: 10.3390/ijerph17207589.
Prison inmates are highly susceptible for several infectious diseases, including vaccine-preventable diseases. We conducted a systematic international literature review on vaccination coverage against hepatitis B virus (HBV), hepatitis A virus (HAV), combined HAV/HBV, tetanus-diphtheria, influenza, pneumococcal, and combined measles, mumps, and rubella (MMR) in prison inmates, according to the PRISMA guidelines. The electronic databases were used Web of Science, MEDLINE, Scopus, and Cinhal. No language or time limit were applied to the search. We defined vaccination coverage as the proportion of vaccinated prisoners. There were no limitations in the search strategy regarding time period or language. Of 1079 identified studies, 28 studies were included in the review. In total, 21 reported on HBV vaccine coverage (range between 16-82%); three on HAV (range between 91-96%); two studies on combined HAV/HBV (77% in the second dose and 58% in the third); three studies on influenza vaccine (range between 36-46%), one of pneumococcal vaccine coverage (12%), and one on MMR coverage (74%). We found that data on vaccination coverage in prison inmates are scarce, heterogeneous, and do not include all relevant vaccines for this group. Current published literature indicate that prison inmates are under-immunized, particularly against HBV, influenza, MMR, and pneumococci. Strengthen immunization programs specifically for this population at risk and improvement of data record systems may contribute to better health care in prisoners.
囚犯极易感染多种传染病,包括可通过疫苗预防的疾病。我们根据 PRISMA 指南,对囚犯接种乙型肝炎病毒 (HBV)、甲型肝炎病毒 (HAV)、HBV/HAV 联合疫苗、破伤风类毒素-白喉类毒素、流感、肺炎球菌、麻疹-腮腺炎-风疹(MMR)疫苗的覆盖情况进行了系统的国际文献回顾。使用了 Web of Science、MEDLINE、Scopus 和 Cinhal 电子数据库进行检索。搜索未设置语言或时间限制。我们将疫苗接种覆盖率定义为已接种疫苗的囚犯比例。搜索策略在时间段或语言方面没有限制。在 1079 项已确定的研究中,有 28 项研究纳入了综述。共有 21 项研究报告了 HBV 疫苗覆盖率(范围在 16%-82%之间);3 项研究报告了 HAV 疫苗覆盖率(范围在 91%-96%之间);2 项研究报告了 HAV/HBV 联合疫苗覆盖率(第二剂为 77%,第三剂为 58%);3 项研究报告了流感疫苗覆盖率(范围在 36%-46%之间),1 项研究报告了肺炎球菌疫苗覆盖率(12%),1 项研究报告了 MMR 疫苗覆盖率(74%)。我们发现,囚犯疫苗接种覆盖率的数据稀缺、异质,且未包括该人群所有相关疫苗。现有文献表明,囚犯的免疫接种率较低,尤其是针对 HBV、流感、MMR 和肺炎球菌。针对这一高危人群加强免疫计划,并改善数据记录系统,可能有助于改善囚犯的医疗保健。